SAMPA SIGNED
Scale-up of an Advanced Manufacturing process to produce a Pharmaceutical product Application (SAMPA).
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0SAMPA project word cloud
Explore the words cloud of the SAMPA project. It provides you a very rough idea of what is the project "SAMPA" about.
Project "SAMPA" data sheet
The following table provides information about the project.
| Coordinator |
SIGMOID PHARMA LIMITED
Organization address contact info |
| Coordinator Country | Ireland [IE] |
| Project website | https://www.sublimitytherapeutics.com/about/sampa-grant/ |
| Total cost | 2˙307˙500 € |
| EC max contribution | 1˙600˙000 € (69%) |
| Programme |
1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) 2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies) |
| Code Call | H2020-SMEINST-2-2014 |
| Funding Scheme | SME-2 |
| Starting year | 2015 |
| Duration (year-month-day) | from 2015-07-01 to 2017-03-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | SIGMOID PHARMA LIMITED | IE (DUBLIN) | coordinator | 1˙600˙000.00 |
Map
Project objective
Sigmoid Pharma has developed an innovative product, CyCol®, to treat patients with moderate-severe ulcerative colitis, a disease that affects 1 million patients in Europe. CyCol® is enabled using Sigmoid’s proprietary SmPill® nanoemulsion-based technology to target a known and powerful drug, cyclosporine, directly to inflamed colons. In Phase II human studies, CyCol® was proven to be effective and safe. CyCol®, on oral product, will compete with injected, expensive drugs that have a risk of serious side effects.
Successful development and commercialisation of CyCol® will pivot on scaling up the advanced manufacturing process from the current ~5kg to the ~50kg batch size required for Phase III human studies.
SAMPA (Scale-up of an Advanced Manufacturing process to produce a Pharmaceutical product Application) project is focused on achieving 50kg batches. It will involve leading EU-based specialist SME technology and equipment suppliers as well as a number of knowledge providers. The requested budget is €1.6M and will be completed in 21 months.
Successful completion of this project will retain and enhance intellectual property and know-how in Sigmoid, increase long term high skill jobs. In parallel, the project will unlock the value inherent not only of CyCol®, but also the underlying SmPill® technology platform. Furthermore, the project will increase the probability of overall company success and increase significantly the NPV to more than €500M.
Deliverables
| Project website | Websites, patent fillings, videos etc. | 2019-11-28 17:28:20 |
Take a look to the deliverables list in detail: detailed list of SAMPA deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SAMPA" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "SAMPA" are provided by the European Opendata Portal: CORDIS opendata.